(Q43169381)

15 November 2017

0 references

CHEK2 I157T associates with familial and sporadic colorectal cancer (English)

1 reference

15 November 2017

1 reference

4

1 reference

15 November 2017

5

1 reference

15 November 2017

O Kilpivaara

1

1 reference

15 November 2017

P Alhopuro

series ordinal

2

1 reference

15 November 2017

P Vahteristo

series ordinal

3

1 reference

15 November 2017

language of work or name

English

0 references

publication date

1 July 2006

1 reference

Journal of Medical Genetics

15 November 2017

1 reference

15 November 2017

43

1 reference

15 November 2017

7

1 reference

15 November 2017

e34

1 reference

CHEK2 is a multiorgan cancer susceptibility gene

15 November 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2564563

CHEK2*1100delC and susceptibility to breast cancer: a collaborative analysis involving 10,860 breast cancer cases and 9,065 controls from 10 studies

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2564563

CHEK2 variants associate with hereditary prostate cancer

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2564563

Chk1 and Chk2 kinases in checkpoint control and cancer

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2564563

The CHEK2 1100delC mutation identifies families with a hereditary breast and colorectal cancer phenotype

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2564563

Variants in CHEK2 other than 1100delC do not make a major contribution to breast cancer susceptibility

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2564563

The mismatch repair system is required for S-phase checkpoint activation

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2564563

A CHEK2 genetic variant contributing to a substantial fraction of familial breast cancer

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2564563

Structural and functional versatility of the FHA domain in DNA-damage signaling by the tumor suppressor kinase Chk2

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2564563

Low-penetrance susceptibility to breast cancer due to CHEK2(*)1100delC in noncarriers of BRCA1 or BRCA2 mutations

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2564563

Functional impact of concomitant versus alternative defects in the Chk2-p53 tumour suppressor pathway.

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2564563

The ATM-Chk2-Cdc25A checkpoint pathway guards against radioresistant DNA synthesis

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2564563

Characterization of tumor-associated Chk2 mutations

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2564563

CHEK2 variant I157T may be associated with increased breast cancer risk

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2564563

Limited relevance of the CHEK2 gene in hereditary breast cancer

15 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2564563

A novel founder CHEK2 mutation is associated with increased prostate cancer risk

15 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2564563

CHEK2 1100delC and colorectal cancer

15 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2564563

Regulation of the Chk2 protein kinase by oligomerization-mediated cis- and trans-phosphorylation

15 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2564563

Population-based molecular detection of hereditary nonpolyposis colorectal cancer

15 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2564563

Colorectal cancer and theCHEK2 1100delC mutation

15 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2564563

Incidence of Hereditary Nonpolyposis Colorectal Cancer and the Feasibility of Molecular Screening for the Disease

1 December 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2564563

Association of two mutations in theCHEK2 gene with breast cancer

1 December 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/16816021

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Contribution of the CHEK2 1100delC variant to risk of multiple colorectal adenoma and carcinoma

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/16816021

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1136/JMG.2005.038331

1 reference

15 November 2017

1 reference

15 November 2017

PubMed publication ID

16816021

1 reference